image004

Analytica Vietnam

April 2 – 4, 2025 Saigon, Vietnam

foresight lab

Major funding boost for molecular imaging in drug development

FORESIGHT consortium receives €9 million grant to accelerate drug development through advanced imaging technologies, addressing challenges in treating rising disease burdens across multiple therapeutic areas.

Biotech Fluidics introduces new flowmeter kit for HPLC pump validation

Biotech Fluidics introduces new flowmeter kit for HPLC pump validation

Biotech Fluidics has developed a new HPLC Pump Validation Kit designed to address longstanding challenges in monitoring highperformance liquid chromatography (HPLC) pump performance. The novel system utilises non-invasive thermal sensor technology to provide real-time validation data, offering laboratory scientists enhanced capabilities for ensuring stable solvent flow critical for accurate chromatographic separations.

AMSBIO launches ready-to-use hiPSC-derived cells for medical research

AMSBIO launches ready-to-use hiPSC-derived cells for medical research

AMSBIO introduces pre-differentiated human induced Pluripotent Stem Cell (hiPSC)-derived cells, offering researchers fully functional cardiomyocytes, hepatocytes and neurons without time-consuming in-house differentiation procedures, potentially transforming research workflows and accelerating discovery timelines.

GeneDx unveils ultrarapid whole genome sequencing for critical paediatric care

GeneDx has unveiled an ultrarapid whole genome sequencing service delivering diagnostic results for critically ill neonatal and paediatric patients within 48 hours. This technological advancement could potentially generate healthcare savings exceeding $15,000 per child while significantly enhancing clinical outcomes through earlier intervention.

Testa Analytical

Testa Analytical unveils breakthrough in molecular weight determination precision

Testa Analytical has released a differential refractometer that promises to significantly improve the accuracy of molecular weight determination in biopolymers and polymers. The instrument, designed specifically as an accessory for light scattering equipment, addresses one of the fundamental challenges in molecular characterisation: obtaining precise specific refractive index increment (dn/dc) values.

mimetas

MIMETAS unveils breakthrough in flow system technology for disease modelling

MIMETAS has introduced OrganoPlate UniFlow (UF), the first commercial platform offering unidirectional, gravity-driven pumpless flow systems for disease research. This innovation significantly advances tissue model development for pharmaceutical research by replicating physiological conditions without complex equipment.

CN Bio DILI Kit

CN Bio releases new in vitro DILI assay kit for toxicology screening

CN Bio has launched an all-in-one drug-induced liver injury (DILI) testing kit that enables pharmaceutical researchers to conduct in-house hepatotoxicity screening using organ-on-chip technology. The system provides human-relevant data to support more informed candidate selection during preclinical development.

EDX Medical

Edx Medical pioneers multi-biomarker testing approach for prostate cancer detection

Cambridge scientists at EDX Medical Group have developed an innovative diagnostic test for prostate cancer that combines over 100 biomarkers with AI analysis, potentially transforming screening accuracy with sensitivity and specificity rates between 96-99%.

Professor Bo Wang, Senior Advisor, Shift Bioscience

AI-powered virtual cell platform expands as Shift Bioscience establishes Toronto base

The Cambridge-based biotech company Shift Bioscience has announced the establishment of new facilities in Toronto, Canada, marking a strategic expansion of their AI capabilities in the development of virtual cell technology. The move follows their recent $16M seed funding round and positions the company to tap into North America’s rich pool of artificial intelligence talent.